Rotavirus Vaccines: Effectiveness, Safety, and Future Directions
- 31 January 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pediatric Drugs
- Vol. 20 (3), 223-233
- https://doi.org/10.1007/s40272-018-0283-3
Abstract
Rotavirus is the leading cause of diarrheal death among children < 5 years old worldwide, estimated to have caused ~ 215,000 deaths in 2013. Prior to rotavirus vaccine implementation, > 65% of children had at least one rotavirus diarrhea illness by 5 years of age and rotavirus accounted for > 40% of all-cause diarrhea hospitalizations globally. Two live, oral rotavirus vaccines have been implemented nationally in > 100 countries since 2006 and their use has substantially reduced the burden of severe diarrheal illness in all settings. Vaccine efficacy and effectiveness estimates suggest there is a gradient in vaccine performance between low child-mortality countries (> 90%) and medium and high child-mortality countries (57–75%). Additionally, an increased risk of intussusception (~ 1–6 per 100,000 vaccinated infants) following vaccination has been documented in some countries, but this is outweighed by the large benefits of vaccination. Two additional live, oral rotavirus vaccines were recently licensed and these have improved on some programmatic limitations of earlier vaccines, such as heat stability, cost, and cold-chain footprint. Non-replicating rotavirus vaccines that are parenterally administered are in clinical testing, and these have the potential to reduce the performance differential and safety concerns associated with live oral rotavirus vaccines.Keywords
This publication has 94 references indexed in Scilit:
- Protective Effect of Natural Rotavirus Infection in an Indian Birth CohortThe New England Journal of Medicine, 2011
- Decline in Diarrhea Mortality and Admissions after Routine Childhood Rotavirus Immunization in Brazil: A Time-Series AnalysisPLoS Medicine, 2011
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Dissolving polymer microneedle patches for influenza vaccinationNature Medicine, 2010
- Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension StudyEuropean Journal of Pediatrics, 2010
- Effect of Rotavirus Vaccination on Death from Childhood Diarrhea in MexicoThe New England Journal of Medicine, 2010
- Oral Rotavirus Vaccines: How Well Will They Work Where They Are Needed Most?The Journal of Infectious Diseases, 2009
- Rotaviruses: From Pathogenesis to VaccinationGastroenterology, 2009